Abstract
Alterations in reward processing are implicated in the pathogenesis of depression, yet their exact mechanism, particularly their role in the treatment of depression remains unclear. This study uses lurasidone, a novel drug with antidepressant properties, to probe mechanisms of reward in young people across the spectrum of depression scores and examines how lurasidone modifies activity in the brain’s reward network.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the American Academy of Child & Adolescent Psychiatry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
